Papakyriacou, Irineos
Kutkaite, Ginte http://orcid.org/0000-0002-2918-294X
Rúbies Bedós, Marta http://orcid.org/0000-0003-0949-4329
Nagarajan, Divya
Alford, Liam P.
Menden, Michael P. http://orcid.org/0000-0003-0267-5792
Mao, Yumeng http://orcid.org/0000-0001-6142-6628
Funding for this research was provided by:
Vetenskapsrådet (2022-01461)
Science for Life Laboratory (SLL2019/9)
Cancerfonden (220474JIA)
Barncancerfonden (TJ2019-0057)
Stiftelsen för Strategisk Forskning (FFL21-0043)
EC | Horizon 2020 Framework Programme (950293)
Article History
Received: 22 March 2023
Accepted: 17 April 2024
First Online: 27 April 2024
Competing interests
: Y.M. and M.P.M. were former employees of AstraZeneca and hold company shares. Y.M. received funding from Bayer Pharmaceuticals and Novo Nordisk Foundation for unrelated projects. M.P.M. receives funding from Roche and GSK for other projects. Other authors declare no conflict of interest.